Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $176,358,827    

Indirect Value

   $413,822,111      
Total Shares   71,480,988      
Total Value   $590,180,938      


Halozyme Therapeutics Inc $176,338,206 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $176,338,206 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    7   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   48.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-23 4 B $4.67 $400,453 I/I 85,750 970,691 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-17 4 B $4.69 $425,824 I/I 90,794 145,885 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-21 4 B $4.74 $428,188 I/I 90,335 148,817 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 B $4.78 $432,246 I/I 90,428 1,069,299 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-22 4 B $8.11 $447,234 I/I 55,146 1,749,847 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2011-11-21 4 B $8.04 $454,075 I/I 56,477 1,694,701 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2006-09-13 4 B $15.42 $471,405 I/I 30,571 642,834 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-12-11 4 B $6.16 $492,800 I/I 80,000 1,262,000 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-13 4 B $15.63 $500,457 I/I 32,019 829,379 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-24 4 B $4.68 $508,459 I/I 108,645 151,032 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-22 4 B $4.70 $541,379 I/I 115,187 953,541 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-13 4 B $8.74 $574,332 I/I 65,713 3,565,713 2.25 -
PGEN Precigen Inc   •       •       •   2023-08-15 4 B $1.50 $577,301 I/I 380,589 31,718,375 0.01 %
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-29 4 B $4.68 $585,562 I/I 125,120 1,010,201 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-23 4 B $4.67 $600,683 I/I 128,626 150,445 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-11 4 B $5.27 $608,364 I/I 115,439 115,439 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2006-09-06 4 B $14.95 $627,900 I/I 42,000 612,263 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 B $4.78 $648,369 I/I 135,642 154,438 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-04 4 B $7.37 $660,691 I/I 89,646 328,663 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-06-01 4 B $7.39 $732,201 I/I 99,080 283,840 2.25 -
PGEN Precigen Inc Director   –       •       •   2021-11-22 4 B $3.52 $739,979 I/I 206,004 513,665 2.25 %
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-07 4 B $5.26 $779,727 I/I 148,237 1,142,758 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-03 4 A $4.33 $800,569 I/I 184,889 2,276,030 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-22 4 B $4.70 $812,061 I/I 172,779 149,750 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-27 4 S $16.90 $826,866 I/I (48,927) 3,616,655 0 -
  271  Records found
  1   2   3   4   5   6  7   8   9   10   11      
  Page 6 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us